Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
NAMS Position Statements
NAMS: The 2017 Hormone Therapy Position StatementA panel of clinicians and researchers expert in the field of women's health and menopause has revised the NAMS 2012 Position Statement with updated recommendations and areas for future research.
Use of Systemic Hormone Therapy After Age 65Is hormone therapy safe and effective in women over age 65 with vasomotor symptoms of menopause, and what should clinicians consider when prescribing for their older patients?
Journal Article, July 06, 2015
NAMS: The 2012 Hormone Therapy Position StatementWhat does the latest position statement from the North American Menopause Society say about the use of various hormone therapies for menopausal and postmenopausal women?
NAMS on Local Estrogen for Vaginal AtrophyAn evidence-based position statement published by The North American Menopause Society (NAMS) on the role of local vaginal estrogen therapy (ET) for the treatment of vaginal atrophy in postmenopausal